Document is current
Any future updates will be listed below
-
Authors
Memel, Zoe
Thiemann, Anna
Dort, Cooper
Mahadevan, Uma
Beck, Kendall R.
- License Information
-
More Information
Article History
Received: 1 July 2024
Accepted: 11 September 2024
First Online: 22 October 2024
Declarations
:
: ZM—consultant for Neptune Medical. AT—none. CD—none. UM—consultant: Abbvie, Bristol Myers Squibb, Boeringher Ingelheim, Celltrion, Enveda, Gilead, Janssen, Lilly, Merck, Pfizer, Protagonist, Rani Therapeutics, Roivant, and Takeda. KB—site-specific principle investigator for AbbVie, Gilead, and NorthSea Clinical Trials.
: This study was approved by the Institutional Review Board (IRB) at the University of California San Francisco (IRB number 23-39463) and was conducted in accordance with the University’s research and patient-specific guidelines. All personnel involved in this study underwent CITI Human Subjects Protection Training. As this was a retrospective study, using de-identified data, the requirement for informed consent was waived.
